Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: A large retrospective study

Among patients with ABTC, 25% received CT2, typically younger patients and those with longer PFS following CT1. Disease control occurred in 43% of patients, and more often with a doublet than a single agent. However, clearly more effective therapies must be found.